Results

CBOE Holdings Inc.

04/16/2019 | Press release | Distributed by Public on 04/16/2019 04:40

FDA Agrees to Rolling Review of Mesoblast's Biologics License Application for Its Cell Therapy in Children With Steroid-Refractory Acute Graft Versus Host Disease



FDA Agrees to Rolling Review of Mesoblast's Biologics License Application for Its Cell Therapy in Children With Steroid-Refractory Acute Graft Versus Host Disease

Benzinga Newsdesk      4/16/2019 5:15:45 AM